TM
EBS icon

Torren Management’s Emergent Biosolutions EBS Stock Holding History

Torren Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15K Hold
137
– – ﹤0.01% 710
2026
Q1 		$1.14K Sell
137
-2,858
-95% -$29.6K ﹤0.01% 710
2025
Q4 		$37K Buy
+2,995
New +$32.1K 0.02% 412

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Torren Management's EBS Position: Q2 2026 in Review

Torren Management held its Emergent Biosolutions (EBS) position steady in Q2 2026 at 137 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #710.

Torren Management first reported a position in EBS in Q4 2025 and has held it in 3 quarters since. The position peaked at $37K in Q4 2025. 68 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Torren Management held 137 shares of Emergent Biosolutions worth $1.15K as of Q2 2026.
  • Torren Management left its Emergent Biosolutions share count unchanged in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of Torren Management's portfolio in Q2 2026, its #710 holding.
  • Torren Management first reported a position in Emergent Biosolutions in Q4 2025 and has held it in 3 quarters since.
  • Torren Management's Emergent Biosolutions position peaked at $37K in Q4 2025.
  • 68 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.